151 related articles for article (PubMed ID: 7920160)
61. Gene therapy: the end of the rainbow?
Shillitoe EJ
Head Neck Oncol; 2009 Mar; 1():7. PubMed ID: 19331651
[TBL] [Abstract][Full Text] [Related]
62. Dendrimers-delivered short hairpin RNA targeting hTERT inhibits oral cancer cell growth in vitro and in vivo.
Liu X; Huang H; Wang J; Wang C; Wang M; Zhang B; Pan C
Biochem Pharmacol; 2011 Jul; 82(1):17-23. PubMed ID: 21453684
[TBL] [Abstract][Full Text] [Related]
63. Gene therapy: a bold direction for HIV-1 treatment.
Sarver N; Rossi J
AIDS Res Hum Retroviruses; 1993 May; 9(5):483-7. PubMed ID: 8391287
[No Abstract] [Full Text] [Related]
64. Functional evidence for involvement of multiple putative tumor suppressor genes on the short arm of chromosome 3 in human oral squamous cell carcinogenesis.
Uzawa N; Yoshida MA; Hosoe S; Oshimura M; Amagasa T; Ikeuchi T
Cancer Genet Cytogenet; 1998 Dec; 107(2):125-31. PubMed ID: 9844607
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR
J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256
[TBL] [Abstract][Full Text] [Related]
66. This month in investigative urology. Commentary on the clinical relevance of gene therapy.
Manyak MJ
J Urol; 1994 Aug; 152(2 Pt 1):292-3. PubMed ID: 8015055
[No Abstract] [Full Text] [Related]
67. Non-viral suicide gene therapy in cervical, oral and pharyngeal carcinoma cells with CMV- and EEV-plasmids.
Düzgüneş N; Cheung J; Konopka K
J Gene Med; 2018 Oct; 20(10-11):e3054. PubMed ID: 30172246
[TBL] [Abstract][Full Text] [Related]
68. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
Nash KL; Alexander GJ; Lever AM
J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
[TBL] [Abstract][Full Text] [Related]
69. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.
Abounader R; Ranganathan S; Lal B; Fielding K; Book A; Dietz H; Burger P; Laterra J
J Natl Cancer Inst; 1999 Sep; 91(18):1548-56. PubMed ID: 10491431
[TBL] [Abstract][Full Text] [Related]
70. Molecular biology of human oral cancer.
Wong DT; Todd R; Tsuji T; Donoff RB
Crit Rev Oral Biol Med; 1996; 7(4):319-28. PubMed ID: 8986394
[TBL] [Abstract][Full Text] [Related]
71. Biological principles and clinical development of prostate cancer gene therapy.
Sanda MG
Semin Urol Oncol; 1997 Feb; 15(1):43-55. PubMed ID: 9050139
[TBL] [Abstract][Full Text] [Related]
72. Anti-genes: siRNA, ribozymes and antisense.
Scanlon KJ
Curr Pharm Biotechnol; 2004 Oct; 5(5):415-20. PubMed ID: 15544489
[TBL] [Abstract][Full Text] [Related]
73. Growth-inhibitory effect of adenovirus-mediated p53 gene transfer on medulloblastoma cell line, Daoy, harboring mutant p53.
Lee SH; Kang HS; Rhee CH; Kim MS; Kwon HC; Park MJ; Park IC; Lee CT; Kim CM; Hong SI
Childs Nerv Syst; 2001 Feb; 17(3):134-8. PubMed ID: 11305765
[TBL] [Abstract][Full Text] [Related]
74. The biochemistry of gene therapy for AIDS.
Savarino A; Pescarmona GP; Turco E; Gupta P
Clin Chem Lab Med; 1998 Apr; 36(4):205-10. PubMed ID: 9638344
[TBL] [Abstract][Full Text] [Related]
75. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
[TBL] [Abstract][Full Text] [Related]
76. The use of gene therapy in cancer research and treatment.
Shinohara ET; Lu B; Hallahan DE
Technol Cancer Res Treat; 2004 Oct; 3(5):479-90. PubMed ID: 15453813
[TBL] [Abstract][Full Text] [Related]
77. Computational approaches to the identification of ribozyme target sites.
James W; Cowe E
Methods Mol Biol; 1997; 74():17-26. PubMed ID: 9204416
[No Abstract] [Full Text] [Related]
78. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
[TBL] [Abstract][Full Text] [Related]
79. Ribozyme therapy: RNA enzymes to the rescue.
Jose AM
Yale J Biol Med; 2002; 75(4):215-9. PubMed ID: 12784972
[No Abstract] [Full Text] [Related]
80. RNA-polymerase III-driven expression cassettes in human gene therapy.
Medina MF; Joshi S
Curr Opin Mol Ther; 1999 Oct; 1(5):580-94. PubMed ID: 11249665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
